UBC recently discussed the impact of real world data on the pharmaceutical industry and how it will impact the future of drug development with International Clinical Trials Magazine. UBC’s panel of experts included Annette Stemhagen, Senior Vice President and Chief Scientific Officer; Aaron Berger, Executive Director US Late Stage Operations and Real World Evidence; and Irene Cosmatos, Senior Research Specialist, RWD Epidemiologist.
This article about the development and future of real world data and its place in biopharmaceutical development covers:
- How data collection and analytics have changed in the last decade
- How RWD aided COVID-19 vaccine development
- What other innovations will emerge in clinical trials
- The future of vaccine trials
- And more
To read the full article, click here.
To learn more about UBC’s RWD experience and capabilities, visit here or get in touch with us.
